7 months ago
GPCR
AnalystsChris HowertonChris Howerton's Stock Forecasts
AnalystsChris Howerton
Sectors:
Analyst Ranking
Top 10%
#456 out of 4563 analysts
Average Return
+18.23%
Win Rate
45%27 out of 60
Risk vs Reward
Poor
Good
Chris Howerton's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Provention Bio IncPRVB | +413.28% | $4.67 | $23.97 | 2022-09-19 - 2023-03-14 | Strong Buy |
Celldex Therapeutics IncCLDX | +303.93% | $84.00 | $339.30 | 2012-11-01 - 2013-11-01 | Strong Buy |
Celldex Therapeutics IncCLDX | +280.86% | $89.09 | $339.30 | 2012-11-01 - 2013-11-01 | Strong Buy |
Provention Bio IncPRVB | +246.39% | $6.92 | $23.97 | 2022-10-06 - 2023-03-14 | Strong Buy |
Ardelyx IncARDX | +243.53% | $0.85 | $2.92 | 2022-03-01 - 2023-03-01 | Strong Buy |
Chris Howerton Analyst Color
Get additional color on Chris Howerton's coverage of popular stocks
9 months ago
PNT
Chris Howerton's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Structure Therapeutics IncGPCR | 2 | Strong Buy | $79.00 | +116.85% | Maintains | 7 months ago |
Point Biopharma Global IncPNT | 2 | Strong Buy | $14.00 | +12.00% | Assumes | 9 months ago |
Milestone Pharmaceuticals IncMIST | 3 | Hold | $4.00 | +140.96% | Downgrades | 10 months ago |
Veru IncVERU | 3 | Hold | $1.00 | -24.24% | Upgrades | a year ago |
Provention Bio IncPRVB | 4 | Hold | $25.00 | N/A | Downgrades | a year ago |
Bioxcel Therapeutics IncBTAI | 2 | Hold | $22.00 | N/A | Downgrades | a year ago |
Applied Molecular Transport IncAMTI | 3 | Sell | $0.40 | N/A | Downgrades | a year ago |
Avalo Therapeutics IncAVTX | 3 | Sell | $720.00 | N/A | Downgrades | a year ago |
Compugen LtdCGEN | 2 | Sell | $0.50 | N/A | Downgrades | a year ago |
Urogen Pharma LtdURGN | 1 | Hold | $10.00 | N/A | Downgrades | a year ago |
Mei Pharma IncMEIP | 3 | Sell | $2.00 | N/A | Downgrades | a year ago |
Landos Biopharma IncLABP | 3 | Sell | $1.00 | N/A | Downgrades | a year ago |
Vectivbio Holding AgVECT | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | a year ago |
Avadel Pharmaceuticals PLCAVDL | 3 | Strong Buy | $11.00 | N/A | Upgrades | a year ago |
Iveric Bio IncISEE | 2 | Hold | $20.00 | N/A | Downgrades | a year ago |
Apellis Pharmaceuticals IncAPLS | 2 | Hold | $40.00 | N/A | Downgrades | a year ago |
Harmony Biosciences Holdings IncHRMY | 3 | Strong Buy | $61.00 | N/A | Upgrades | 2 years ago |
Axsome Therapeutics IncAXSM | 3 | Strong Buy | $90.00 | N/A | Maintains | 2 years ago |
Finch Therapeutics Group IncFNCH | 2 | Strong Buy | $510.00 | N/A | Maintains | 2 years ago |
Karuna Therapeutics IncKRTX | 1 | Strong Buy | $183.00 | N/A | Maintains | 2 years ago |
Ardelyx IncARDX | 3 | Strong Buy | $5.00 | N/A | Upgrades | 2 years ago |
Disc Medicine IncIRON | 2 | Hold | $1.50 | N/A | Downgrades | 2 years ago |
Vanda Pharmaceuticals IncVNDA | 1 | Hold | $12.00 | N/A | Downgrades | 2 years ago |
Arena Pharmaceuticals IncARNA | 1 | Hold | $100.00 | N/A | Downgrades | 2 years ago |
Igm Biosciences IncIGMS | 1 | Strong Buy | $126.00 | N/A | Maintains | 2 years ago |
Io Biotech IncIOBT | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 2 years ago |
Celldex Therapeutics IncCLDX | 9 | Strong Buy | $66.00 | N/A | Initiates Coverage On | 3 years ago |
Omega Therapeutics IncOMGA | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 3 years ago |
Candel Therapeutics IncCADL | 1 | Strong Buy | $22.00 | N/A | Initiates Coverage On | 3 years ago |
Tscan Therapeutics IncTCRX | 1 | Strong Buy | $21.00 | N/A | Initiates Coverage On | 3 years ago |
Werewolf Therapeutics IncHOWL | 1 | Strong Buy | $22.00 | N/A | Initiates Coverage On | 3 years ago |
Lava Therapeutics NvLVTX | 1 | Strong Buy | $23.00 | N/A | Initiates Coverage On | 3 years ago |
Evelo Biosciences IncEVLO | 3 | Strong Buy | $360.00 | N/A | Upgrades | 3 years ago |
Acadia Pharmaceuticals IncACAD | 2 | Hold | $21.00 | N/A | Downgrades | 3 years ago |
Alaunos Therapeutics IncTCRT | 1 | Hold | $5.00 | N/A | Downgrades | 3 years ago |
Pluri IncPLUR | 2 | Hold | $6.00 | N/A | Downgrades | 3 years ago |
Immunomedics IncIMMU | 1 | Hold | $88.00 | N/A | Downgrades | 4 years ago |
Chiasma IncCHMA | 1 | Strong Buy | $8.00 | N/A | Initiates Coverage On | 4 years ago |
Seres Therapeutics IncMCRB | 1 | Strong Buy | $29.00 | N/A | Upgrades | 4 years ago |
Bellerophon Therapeutics IncBLPH | 1 | Strong Buy | $19.00 | N/A | Initiates Coverage On | 4 years ago |
Therapeuticsmd IncTXMD | 1 | Sell | $60.00 | N/A | Downgrades | 4 years ago |
Corcept Therapeutics IncCORT | 1 | Hold | $16.00 | N/A | Downgrades | 4 years ago |
Protagonist Therapeutics IncPTGX | 1 | Strong Buy | $27.00 | N/A | Initiates Coverage On | 4 years ago |
Lyra Therapeutics IncLYRA | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.